By NextBestFitPrivate equity roll-ups in medicine
Private-equity firms buy physician practices (anesthesia, dermatology, emergency medicine, gastroenterology), nursing homes, and hospices, often raising prices and cutting staff.
Evidence
- Single PE firms hold more than 30% of the market in 108 metropolitan specialty markets; deals rose from 75 (2012) to 484 (2021).
Who's affected
Who is hurt
- People with ongoing or specialist care needs: Practice and facility buyouts can raise prices and cut staff.
- Older and disabled people needing long-term care: Practice and facility buyouts can raise prices and cut staff.
- Doctors, nurses, and other clinicians: Private equity ownership reduces their autonomy.
Who gains while it lasts
- Private equity firms and investors: Investors gain from buying and consolidating medical businesses.
Under your mix of paths
Paths that fix or soften it
Using your saved plan. 0 paths picked.Edit all picks
Root causes
- Fee-for-service arbitrage, out-of-network billing, and roll-up valuations
Related costs
Open questions
- Should investor-owned providers be allowed? With what limits?
Solution paths (2)
Open a path for what it fixes, what it creates or worsens, who gains and who loses, precedents, and how it connects to other paths. See all paths as a decision tree.
Ownership disclosure, review of roll-ups, limits on sale-leasebacks, and liability for owners when facilities are stripped.
- +Private equity roll-ups in medicine
- −Under-investment in equipment and facilities
- −Requires difficult enforcement
Uniform rates and no out-of-network billing remove the arbitrage PE roll-ups rely on.
- +Private equity roll-ups in medicine
- −Solves only part of the problem
- −Nursing and direct-care shortages and burnout